Patents by Inventor Shenglei Chen

Shenglei Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus
    Patent number: 11660337
    Abstract: The present invention discloses a combination of vaccine strains for treating, preventing, relieving or controlling Canine Distemper, Canine Parvovirus Enteritis and Canine Infectious Hepatitis, comprising: Canine Distemper virus vaccine strain with the microorganism deposition accession number CGMCC No. 19397, Canine Parvovirus vaccine strain with the microorganism deposition accession number CGMCC No. 19398 and Canine Infectious Hepatitis virus vaccine strain with the microorganism deposition accession number CGMCC No. 19396. The three vaccine strains of the combination of vaccine strains are low in toxicity and good in immunogenicity. The present invention further discloses a live vaccine composition using the above-mentioned combination of vaccine strains as immunogen. The vaccine composition is safe and effective.
    Type: Grant
    Filed: October 15, 2021
    Date of Patent: May 30, 2023
    Assignee: Liaoning Yikang Biological Corporation Limited
    Inventors: Fengyan Li, Xiuwei Shu, Bo Wang, Yiping Wang, Wenyou Luo, Shenglei Chen, Yanxia Liu
  • TRIPLE LIVE VACCINE OF CANINE DISTEMPER VIRUS, CANINE PARVOVIRUS AND CANINE INFECTIOUS HEPATITIS VIRUS
    Publication number: 20220118083
    Abstract: The present invention discloses a combination of vaccine strains for treating, preventing, relieving or controlling Canine Distemper, Canine Parvovirus Enteritis and Canine Infectious Hepatitis, comprising: Canine Distemper virus vaccine strain with the microorganism deposition accession number CGMCC No. 19397, Canine Parvovirus vaccine strain with the microorganism deposition accession number CGMCC No. 19398 and Canine Infectious Hepatitis virus vaccine strain with the microorganism deposition accession number CGMCC No. 19396. The three vaccine strains of the combination of vaccine strains are low in toxicity and good in immunogenicity. The present invention further discloses a live vaccine composition using the above-mentioned combination of vaccine strains as immunogen. The vaccine composition is safe and effective.
    Type: Application
    Filed: October 15, 2021
    Publication date: April 21, 2022
    Applicant: Liaoning Yikang Biological Corporation Limited
    Inventors: Fengyan Li, Xiuwei Shu, Bo Wang, Yiping Wang, Wenyou Luo, Shenglei Chen, Yanxia Liu